Literature DB >> 16505419

Treatment of advanced head and neck cancer: what lessons have we learned?

Barbara A Conley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505419     DOI: 10.1200/JCO.2005.05.0682

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Withaferin A, a cytotoxic steroid from Vassobia breviflora, induces apoptosis in human head and neck squamous cell carcinoma.

Authors:  Abbas K Samadi; Xiaoqin Tong; Ridhwi Mukerji; Huaping Zhang; Barbara N Timmermann; Mark S Cohen
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

2.  Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.

Authors:  Sarah Wheeler; Doris R Siwak; Raymond Chai; Courtney LaValle; Raja R Seethala; Lin Wang; Kathleen Cieply; Carol Sherer; Corwin Joy; Gordon B Mills; Athanassios Argiris; Jill M Siegfried; Jennifer R Grandis; Ann Marie Egloff
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

3.  Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis.

Authors:  Huajun Feng; Dingting Wang; Jinping Liu; Longfei Zou; Shengen Xu; Zhuoping Liang; Gang Qin
Journal:  J Clin Lab Anal       Date:  2022-05-20       Impact factor: 3.124

4.  Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma.

Authors:  Stephanie M Cohen; Nick Rockefeller; Ridhwi Mukerji; Dianne Durham; M Laird Forrest; Shuang Cai; Mark S Cohen; Yelizaveta Shnayder
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 6.223

5.  Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancer.

Authors:  Mukund Seshadri; Karoly Toth
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

6.  Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts.

Authors:  Mukund Seshadri; Mihai Merzianu; Haikuo Tang; Nestor R Rigual; Maureen Sullivan; Thom R Loree; Saurin R Popat; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

7.  EBV and not HPV sensitizes tobacco-associated head and neck cancer cell line FaDu to radiotherapy.

Authors:  Arunkumar Anandharaj; Oleksandr Ekshyyan; Yali Jia; Xiaohua Rong; Lynn Harrison; Runhua Shi; Rona S Scott; Cherie-Ann O Nathan
Journal:  Acta Otolaryngol       Date:  2015-12-04       Impact factor: 1.494

8.  Hyaluronic acid carrier-based photodynamic therapy for head and neck squamous cell carcinoma.

Authors:  Ti Zhang; Moustafa M Abdelaziz; Shuang Cai; Xinmai Yang; Daniel J Aires; M Laird Forrest
Journal:  Photodiagnosis Photodyn Ther       Date:  2021-12-23       Impact factor: 3.631

9.  Head and neck cancer: value of perfusion CT in depicting primary tumor spread.

Authors:  Agnieszka Trojanowska; Piotr Trojanowski; Andrzej Drop; Tomasz Jargiełło; Janusz Klatka
Journal:  Med Sci Monit       Date:  2012-02

10.  Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients.

Authors:  A Kolk; N Jubitz; K Mengele; K Mantwill; O Bissinger; M Schmitt; M Kremer; P S Holm
Journal:  Br J Cancer       Date:  2011-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.